Human papillomavirus infection : protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in treatment and prevention of recurrence of anogenital warts (HIPvac trial)

Murray, Macey L, Meadows, Jade, Dore, Caroline J. et al. (9 more authors) (2018) Human papillomavirus infection : protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in treatment and prevention of recurrence of anogenital warts (HIPvac trial). BMC Medical Research Methodology. ISSN 1471-2288

Metadata

Authors/Creators:
  • Murray, Macey L
  • Meadows, Jade
  • Dore, Caroline J.
  • Copas, Andrew
  • Haddow, Lewis J.
  • Lacey, Charles John Nash https://orcid.org/0000-0001-9250-2638
  • Jit, M.
  • Soldan, Kate
  • Bennett, Kate
  • Tetlow, Michelle
  • Nathan, Mayura
  • Gilson, Richard
Copyright, Publisher and Additional Information: © The Author(s). 2018.
Dates:
  • Published: 6 November 2018
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Hull York Medical School (York)
Depositing User: Pure (York)
Date Deposited: 22 Feb 2019 10:40
Last Modified: 01 Sep 2019 23:47
Status: Published
Refereed: Yes

Download

Filename: s12874_018_0581_z.pdf

Description: s12874-018-0581-z

Licence: CC-BY 2.5

Share / Export